Delivery Order SPE2DB20D3111-SPE2DB24FA8UA

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract has a ceiling value of $13,215.70 and a completion date of May 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC enables...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 15 mg tablets. The contract has a ceiling value of $1,630.96 and a completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $12,302.02 and covers the delivery of Xarelto 20 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of September 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Xarelto 20mg tablets. The contract has a ceiling value of $16,572.10 and a period of performance through May 15, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract has a firm fixed price, with a ceiling value of $1,558.63, and an ultimate completion date of September 30, 2024. The contract is not set aside for a specific business type. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract has a firm fixed-price pricing type and a ceiling value of $21,527.83. The delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, which has a maximum value of up to $999,999,999 and provides a range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xarelto 20 mg tablets, a prescription medication, with a ceiling value of $5,418.85 and a period of performance through May 19, 2025. The contract is designated as a Firm Fixed Price agreement, with no set-aside used. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,217.83, is for the delivery of Xarelto 20 mg tablets. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XARELTO 20 MG TABLET 90S. The contract has an ultimate completion date of September 19, 2024, and a ceiling value of $1,679.07. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The total contract value is $7,483.98, with a period of performance through December 15, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA8UA
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Xarelto 20 mg tablets. The contract has a ceiling value of $1,220.66 and an ultimate completion date of August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/19/24, 9:22 AM